Search results
Q1 2024 Kroger Co Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day ago...Financial Officer, Chief Accounting Officer, Group Vice President, Corporate Controller; Kroger Co Rupesh Parikh; Analyst; Oppenheimer Robby Ohmes; Analyst; Bank of America Merrill Lynch Ken Goldman; Analyst; JP Morgan John Heinbockel; Analyst; Guggenheim...
10 things to watch in the stock market Friday including more optimism on Apple's AI plan
CNBC· 19 hours agoMy top 10 things to watch Friday, June 21 Stocks are indicated for a slightly lower open Friday...
Perspective Therapeutics (NYSE:CATX) Rating Reiterated by Oppenheimer
ETF DAILY NEWS· 2 days agoPerspective Therapeutics (NYSE:CATX – Get Free Report)‘s stock had its “outperform” rating restated...
Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more
CNBC· 20 hours agoShares dipped 2%, adding to losses from Thursday, when Nvidia closed down 3.5%. The decline comes...
Religious leader wants to display Indian scriptures in Louisiana public classrooms
WVLA Baton Rouge via Yahoo News· 1 day agoThe Hindu statesman noted that multiple prominent Americans were influenced by the Gita including...
Oppenheimer Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target to $25.00
ETF DAILY NEWS· 3 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price objective trimmed by Oppenheimer from $50.00 to $25.00 in a report issued on Tuesday morning, Benzinga reports ...
Women’s PGA Championship 2024: How to Watch the Major Event Online Without Cable
The Hollywood Reporter via Yahoo Sports· 2 days agoThe KPMG Women’s PGA Championship returns to Sahalee Country Club in Sammamish, Washington this...
Delta Stock Is Rebounding. Its CEO Explains Why It Can Fly Higher.
Barrons.com· 14 hours agoThe airline’s chief executive, Ed Bastien, a Barron’s Top CEO, lays out how Delta recovered from a...
Donna Langley Preaches The Power Of Optimism & Meeting Consumers Where They Really Are To Ken...
Deadline via Yahoo News· 8 hours ago“Everyone is talking about the doom and gloom of our industry, but we have to get over that and be...
Oppenheimer Lowers Ovid Therapeutics (NASDAQ:OVID) to Market Perform
ETF DAILY NEWS· 4 days agoOvid Therapeutics (NASDAQ:OVID – Get Free Report) was downgraded by stock analysts at Oppenheimer from an “outperform” rating to a “market perform” rating in a report issued ...
